The 5-HT3 Receptor Antagonist Aloxi(R) Launched In Japan
LUGANO, Switzerland and TOKYO, Japan, April 22, 2010 /PRNewswire/ -- Helsinn Healthcare SA, Switzerland, and Taiho Pharmaceutical Co., Ltd., Japanese licensee of Helsinn's second generation 5-HT3…